1. Bradshaw, M., Rutherford, M. S., Hoeper, B. J., Mc-Whinney, C. D., Borcherding, D. R., Shook, L. B. and Edwards, C. K., Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-α gene expression and protein production using novel enantiomeric carboxylic nucleoside analogues.J Pharmacol. Exp. Ther., 273, 1506–1518 (1995).
2. Chae, S. H., Kim, P. S., Cho, J. Y., Park, J., Lee, J. H., Yoo, E. S., Baik, K. U., Lee, J. and Park, M. H., Isolation and identification of inhibitory compounds on TNF-α production from Flos Magnoliae.The Spring Convention of Pharmaceutical Society of Korea, p. 186 (1997).
3. Dayer, J. M., DE Rochemonteix, B., Burners, B., Demczuk, S. and Dinarello, C. A., Human recombinant interleukin-1 stimulates collagenase and prostaglandin E2 production by human synovial cells.J Clin. Invest., 77, 645–652 (1986).
4. Han, J., Thompson, P. and Beutler, B., Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signalling pathway.J. Exp. Med., 172, 391–394 (1990).
5. Firestein, G. S., Rheumatoid synovitis and pannus, In Klippel, J. and Dieppe, P. (eds.).Rheumatology. Mosby, St. Louis, pp. 3.12.1–3.12.30, 1994.